The osteoprotective role of USP26 in coordinating bone formation and resorption
Open Access
- 29 January 2022
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 29 (6) , 1123-1136
Abstract
Bone homeostasis is maintained through a balance of bone formation by osteoblasts and bone resorption by osteoclasts. Ubiquitin-specific proteases (USPs) are involved in regulating bone metabolism by preserving bone formation or antagonizing bone resorption. However, the specific USPs that maintain bone homeostasis by orchestrating bone formation and bone resorption simultaneously are poorly understood. Here, we identified USP26 as a previously unknown regulator of bone homeostasis that coordinates bone formation and resorption. Mechanistically, USP26 stabilizes β-catenin to promote the osteogenic activity of mesenchymal cells (MSCs) and impairs the osteoclastic differentiation of bone myelomonocytes (BMMs) by stabilizing inhibitors of NF-κBα (IκBα). Gain-of-function experiments revealed thatUsp26supplementation significantly increased bone regeneration in bone defects in aged mice and decreased bone loss resulting from ovariectomy. Taken together, these data show the osteoprotective effect of USP26 via the coordination of bone formation and resorption, suggesting that USP26 represents a potential therapeutic target for osteoporosis.Keywords
This publication has 46 references indexed in Scilit:
- Mesenchymal Stem Cells in Bone RegenerationAdvances in Wound Care, 2013
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Klotho−/− MicePLOS Genetics, 2012
- Osteoprotection by semaphorin 3ANature, 2012
- The Deubiquitinating Enzyme USP26 Is a Regulator of Androgen Receptor SignalingMolecular Cancer Research, 2010
- Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblastsAging Cell, 2008
- Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast DifferentiationDevelopmental Cell, 2005
- Possible role of USP26 in patients with severely impaired spermatogenesisEuropean Journal of Human Genetics, 2004
- Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2–/– Mice by RANKL TransgeneJournal of Biological Chemistry, 2003
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997